NEUE: AI 评分 42/100 — AI 分析 (4月 2026)
NeueHealth, Inc. operates in the healthcare sector, providing services to health consumers, providers, and payors. The company focuses on delivering care through its NeueCare and NeueSolutions segments, targeting the ACA marketplace, Medicare, and Medicaid.
Key Facts:
AI Score: 42/100
Sector: Healthcare
公司概况
概要：
NeueHealth, Inc. operates in the healthcare sector, providing services to health consumers, providers, and payors. The company focuses on delivering care through its NeueCare and NeueSolutions segments, targeting the ACA marketplace, Medicare, and Medicaid.
NeueHealth, Inc. delivers healthcare services through its NeueCare and NeueSolutions segments, focusing on the ACA marketplace, Medicare, and Medicaid. Operating risk-bearing clinics and enabling providers in performance-based arrangements, NeueHealth aims to improve healthcare access and outcomes in a competitive landscape.
NEUE是做什么的？
NeueHealth, Inc., established in 2015 and headquartered in Doral, Florida, is a healthcare company focused on providing a range of services to health consumers, providers, and payors in the United States. Formerly known as Bright Health Group, Inc., the company rebranded to NeueHealth, Inc. in January 2024, signaling a strategic shift in its business approach. NeueHealth operates through two primary segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to individuals covered by the ACA marketplace, Medicare, and Medicaid through a network of owned and affiliated clinics. These clinics operate under the brand names Centrum Health, AssociatesMD, and Premier Medical Associates. The segment offers an integrated system care solution, including embedded pharmacy, laboratory, radiology, and population health focused specialty services. It also provides chronic care management, transitions of care, and referral management services. The NeueSolutions segment focuses on enabling providers and medical groups to succeed in performance-based arrangements. This segment also participates in programs designed to improve healthcare access for Medicare beneficiaries. NeueHealth's business model is centered around providing comprehensive and coordinated care, leveraging technology and data analytics to improve patient outcomes and reduce costs. The company aims to create a more efficient and effective healthcare system by aligning incentives and empowering providers to deliver high-quality care.
NEUE的投资论点是什么？
NeueHealth, Inc. presents a complex investment case. The company's focus on the ACA marketplace, Medicare, and Medicaid offers exposure to growing segments of the healthcare market. The NeueCare segment's integrated care model, with embedded services like pharmacy and lab, could drive efficiencies and improve patient outcomes. However, the company's negative P/E ratio of -0.62 and a negative profit margin of -10.7% indicate current challenges in achieving profitability. The company's market capitalization is $0.06 billion as of March 2026. Key catalysts include successful expansion of the NeueCare clinic network and increased adoption of the NeueSolutions platform by providers. Risks include regulatory changes in the healthcare industry and the company's ability to manage medical costs effectively.
NEUE在哪个行业运营？
NeueHealth operates in the dynamic and highly regulated healthcare industry. The industry is characterized by increasing demand for value-based care, driven by rising healthcare costs and a growing emphasis on patient outcomes. The competitive landscape includes established players such as ACHL, AKYA, CCLD, HTBX, and NAKA, as well as new entrants focused on innovative care delivery models. NeueHealth's focus on integrated care and performance-based arrangements aligns with industry trends, but the company faces challenges in scaling its operations and achieving profitability in a competitive market.
Medical - Equipment & Services
Healthcare
NEUE有哪些增长机遇？
- Expansion of NeueCare Clinic Network: NeueHealth can expand its network of owned and affiliated clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brands. This expansion would allow the company to reach more patients and increase its market share in key geographic areas. The market for primary care services is estimated at $260 billion annually, providing a significant opportunity for growth. Timeline: Ongoing.
- Adoption of NeueSolutions Platform: The NeueSolutions segment can drive growth by increasing adoption of its platform among providers and medical groups. This platform enables providers to succeed in performance-based arrangements, which are becoming increasingly prevalent in the healthcare industry. The market for value-based care solutions is projected to reach $1 trillion by 2028. Timeline: Ongoing.
- Strategic Partnerships: NeueHealth can form strategic partnerships with other healthcare providers, payors, and technology companies to expand its reach and enhance its service offerings. These partnerships could provide access to new markets, technologies, and expertise. The market for healthcare partnerships is growing rapidly, with a focus on collaboration and innovation. Timeline: Ongoing.
- Technology Integration: Investing in technology to improve care coordination, patient engagement, and data analytics can drive growth and improve efficiency. This includes implementing telehealth solutions, developing mobile apps for patients, and using data analytics to identify and manage high-risk patients. The market for healthcare technology is projected to reach $390 billion by 2024. Timeline: Ongoing.
- Medicare Advantage Expansion: NeueHealth can expand its presence in the Medicare Advantage market, which is experiencing significant growth due to the aging population and increasing popularity of managed care plans. This expansion would allow the company to tap into a large and growing market segment. The Medicare Advantage market is projected to reach $590 billion by 2027. Timeline: Ongoing.
- Market capitalization of $0.06 billion indicates a small-cap company with potential for growth but also higher volatility.
- P/E ratio of -0.62 reflects current unprofitability, requiring scrutiny of turnaround strategies.
- Gross margin of 24.2% suggests potential for improvement through cost management and operational efficiencies.
- Beta of 0.60 indicates lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- The company rebranded from Bright Health Group, Inc. to NeueHealth, Inc. in January 2024, signaling a strategic shift.
NEUE提供哪些产品和服务？
- Provides healthcare services to health consumers, providers, and payors in the United States.
- Operates through NeueCare and NeueSolutions segments.
- Delivers healthcare services to ACA marketplace, Medicare, and Medicaid enrollees.
- Operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brands.
- Offers integrated system care solutions, including pharmacy, laboratory, and radiology services.
- Provides chronic care management, transitions of care, and referral management services.
- Enables providers and medical groups to succeed in performance-based arrangements.
- Participates in programs designed to improve healthcare access for Medicare beneficiaries.
NEUE如何赚钱？
- Generates revenue through providing healthcare services to patients in its owned and affiliated clinics.
- Earns fees from providers and medical groups for using the NeueSolutions platform.
- Participates in risk-sharing arrangements with payors, where it shares in the cost savings generated by its care management programs.
- Health consumers enrolled in ACA marketplace, Medicare, and Medicaid plans.
- Providers and medical groups seeking to improve their performance in value-based care arrangements.
- Payors looking to partner with organizations that can help them manage costs and improve patient outcomes.
- Integrated Care Model: NeueHealth's integrated care model, with embedded services like pharmacy and lab, provides a competitive advantage by improving care coordination and patient convenience.
- Proprietary Technology Platform: The NeueSolutions platform provides a competitive advantage by enabling providers to succeed in performance-based arrangements.
- Established Clinic Network: The company's network of owned and affiliated clinics provides a strong foundation for growth and expansion.
什么因素可能推动NEUE股价上涨？
- Upcoming: Expansion of the NeueCare clinic network into new geographic markets by Q4 2026.
- Ongoing: Increased adoption of the NeueSolutions platform by providers and medical groups.
- Ongoing: Strategic partnerships with other healthcare organizations to expand service offerings.
- Upcoming: Positive regulatory changes in the healthcare industry that support value-based care initiatives.
NEUE的主要风险是什么？
- Potential: Regulatory changes in the healthcare industry that could negatively impact NeueHealth's business model.
- Ongoing: Increasing competition from established players and new entrants in the healthcare market.
- Ongoing: Rising medical costs that could erode profit margins.
- Potential: Economic downturn that could reduce demand for healthcare services.
NEUE的核心优势是什么？
- Integrated care model with embedded services.
- Proprietary technology platform for value-based care.
- Established clinic network.
- Focus on growing segments of the healthcare market (ACA, Medicare, Medicaid).
NEUE的劣势是什么？
- Negative P/E ratio and profit margin.
- Small market capitalization.
- Limited brand recognition.
- High level of competition in the healthcare industry.
NEUE有哪些机遇？
- Expansion of clinic network.
- Increased adoption of NeueSolutions platform.
- Strategic partnerships.
- Medicare Advantage expansion.
NEUE面临哪些威胁？
- Regulatory changes in the healthcare industry.
- Increasing competition.
- Rising medical costs.
- Economic downturn.
NEUE的竞争对手是谁？
- Arch হেল্থ — Focuses on digital health solutions and virtual care. — (ACHL)
- Akoya BioSciences, Inc. — Provides spatial biology solutions for research and clinical applications. — (AKYA)
- CareCloud, Inc. — Offers cloud-based healthcare solutions for medical practices. — (CCLD)
- Heat Biologics, Inc. — Develops immunotherapies for cancer and infectious diseases. — (HTBX)
- Nakama Group PLC — Provides recruitment services for the digital, creative, and technology sectors. — (NAKA)
Key Metrics
- MoonshotScore: 42/100
Company Profile
- CEO: George Lawrence Mikan III
- Headquarters: Doral, US
- Employees: 986
- Founded: 2021
AI Insight
AI analysis pending for NEUE
常见问题
What does NeueHealth, Inc. do?
NeueHealth, Inc. operates as a healthcare services company, providing solutions for health consumers, providers, and payors. Through its NeueCare segment, NeueHealth delivers healthcare services via owned and affiliated clinics, targeting the ACA marketplace, Medicare, and Medicaid populations. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements. NeueHealth aims to improve healthcare access and outcomes by offering integrated care solutions and leveraging technology to enhance care coordination and efficiency.
What do analysts say about NEUE stock?
Analyst coverage of NeueHealth, Inc. (NEUE) is currently limited, reflecting its small-cap status and recent strategic shift. Key valuation metrics, such as the negative P/E ratio, suggest caution. Growth considerations center on the company's ability to scale its NeueCare clinic network, expand the adoption of its NeueSolutions platform, and manage medical costs effectively. Investors should closely monitor the company's financial performance and progress in achieving profitability.
What are the main risks for NEUE?
NeueHealth, Inc. faces several key risks, including regulatory changes in the healthcare industry, increasing competition from established players and new entrants, and rising medical costs. The company's reliance on the ACA marketplace, Medicare, and Medicaid makes it vulnerable to policy changes and reimbursement pressures. Additionally, NeueHealth's ability to manage medical costs effectively is critical to its profitability and long-term success. The company's small market capitalization also exposes it to higher volatility and liquidity risks.